EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+11.12%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$915M
AUM Growth
+$915M
(-2%)
Cap. Flow
-$40.9M
Cap. Flow
% of AUM
-4.48%
Top 10 Holdings %
Top 10 Hldgs %
78.79%
Holding
44
New
14
Increased
4
Reduced
6
Closed
14
Top Buys
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$55.8M |
| 2 |
Scholar Rock
SRRK
|
$41.7M |
| 3 |
UBX
Unity Biotechnology
UBX
|
$25.3M |
| 4 |
Kezar Life Sciences
KZR
|
$22M |
| 5 |
Sangamo Therapeutics
SGMO
|
$21.4M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$49.8M |
| 2 |
Wave Life Sciences
WVE
|
$40M |
| 3 |
Ascendis Pharma
ASND
|
$23.8M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$23.4M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$22.1M |
Sector Composition
| 1 | Healthcare | 93.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
FibroGen
FGEN
$47.8M
| $126M | 12.02% | 2,017,250 +14,813 | +0.7% | +$927K |
|
2
Ironwood Pharmaceuticals
IRWD
$214M
| $120M | 11.38% | 6,250,073 +364,490 | +6% | +$6.97M |
|
3
Assembly Biosciences
ASMB
$190M
| $115M | 10.99% | 2,943,164 -1 | -0% | -$39 |
|
|
4
Ascendis Pharma
ASND
$11.8B
| $97.4M | 9.27% | 1,464,067 -358,508 | -20% | -$23.8M |
|
5
Kura Oncology
KURA
$686M
| $71.1M | 6.77% | 3,904,675 +137,823 | +4% | +$2.51M |
|
|
6
Madrigal Pharmaceuticals
MDGL
$9.76B
| $55.8M | 5.31% | +199,500 | New | +$55.8M |
|
|
7
Scholar Rock
SRRK
$3.14B
| $41.7M | 3.97% | +2,671,161 | New | +$41.7M |
|
|
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $36.3M | 3.45% | 2,961,147 -1,803,300 | -38% | -$22.1M |
|
9
MacroGenics
MGNX
$112M
| $30M | 2.85% | 1,450,606 | – | – |
|
10
Arcus Biosciences
RCUS
$1.13B
| $27.4M | 2.61% | 2,236,387 | – | – |
|
|
UBX
11
DELISTED
Unity Biotechnology
UBX
| $25.3M | 2.41% | +1,680,644 | New | +$25.3M |
|
|
12
Kezar Life Sciences
KZR
$28.9M
| $22M | 2.1% | +1,272,198 | New | +$22M |
|
|
13
Sangamo Therapeutics
SGMO
$157M
| $21.4M | 2.04% | +1,509,671 | New | +$21.4M |
|
14
Dianthus Therapeutics
DNTH
$759M
| $20.8M | 1.98% | +1,538,088 | New | +$20.8M |
|
|
IMDZ
15
DELISTED
Immune Design Corp.
IMDZ
| $20.2M | 1.92% | 4,437,600 | – | – |
|
|
16
Wave Life Sciences
WVE
$1.53B
| $15.8M | 1.5% | 412,871 -1,046,201 | -72% | -$40M |
|
|
SURF
17
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $14.5M | 1.38% | +890,808 | New | +$14.5M |
|
|
EIGR
18
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $12.7M | 1.21% | +1,039,500 | New | +$12.7M |
|
|
ACHN
19
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $11M | 1.05% | 3,887,407 +219,100 | +6% | +$620K |
|
|
KDMN
20
DELISTED
Kadmon Holdings, Inc.
KDMN
| $9.98M | 0.95% | +2,500,000 | New | +$9.98M |
|
|
DBVT
21
DBV Technologies
DBVT
$264M
| $5.75M | 0.55% | 298,100 -151,900 | -34% | -$2.93M |
|
22
Corvus Pharmaceuticals
CRVS
$428M
| $4.95M | 0.47% | 450,400 -19,300 | -4% | -$212K |
|
23
Neurogene
NGNE
$264M
| $3.05M | 0.29% | +1,150,000 | New | +$3.05M |
|
24
Traws Pharma
TRAW
$9.89M
| $3.03M | 0.29% | +7,500,000 | New | +$3.03M |
|
|
PHXM
25
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $1.73M | 0.17% | +153,964 | New | +$1.73M |
|